DCIS: Research and Treatment Update
When: Thursday, May 17, 2012
12:00 p.m. - 1:15 p.m. ET
During our free May teleconference, David M. Euhus, MD, discussed the importance of new research on ductal carcinoma in situ (DCIS) reported at the San Antonio Breast Cancer Symposium. At this teleconference, participants learned about:
- Surgical considerations in treating DCIS
- The risk of developing invasive breast cancer
- The role of radiation therapy and when hormonal therapy can be helpful
About Our Speaker
David M. Euhus, MD, is a faculty member at UT Southwestern Medical Center in Dallas. He is also the author of the popular CancerGene software program, which is used for genetic risk assessment in more than 4,000 cancer centers worldwide.
Dr. Euhus performed an internship, surgical residency and surgical oncology fellowship at UCLA Medical Center in Los Angeles, Calif. He then served as a surgical oncologist in the U.S. Army for five years before joining the faculty at U.T. Southwestern Medical Center in 1996.
This teleconference is sponsored by Genomic Health.